If you’ve spent the last decade using a smartphone, you’ve watched as Silicon Valley tech conglomerates systematically colonized every square inch of your daily life. First, they tracked your steps. Then they tracked your sleep. Then they tracked your screen time, your heart rate, and your breathing.
But apparently, that wasn’t enough data to feed the insatiable appetite of the corporate artificial intelligence machines.
In a massive, multi-year partnership announced on August 11, 2026, medical device giant Abbott and Google Health have joined forces to put a corporate toll booth directly inside your bloodstream. The collaboration integrates Abbott’s “Lingo” over-the-counter continuous glucose monitor (CGM) with Google’s AI consumer tech. Under this new setup, Google’s “Health Coach” AI will analyze your real-time blood sugar trends alongside other wellness metrics to deliver personalized, “contextual” behavioral recommendations directly inside the Google Health app.
The marketing material is predictably slick and therapeutic. It promises to “redefine how people understand and manage their health,” helping you make “meaningful lifestyle changes” in response to nutrition, sleep, and stress.
But let’s look at this with some raw, independent-minded common sense.
Since when did eating an apple, taking a 15-minute walk, or having a slice of birthday cake require a multi-billion-dollar corporate AI to translate our body’s responses for us?
Human beings have possessed a highly advanced, evolutionary biowearable for hundreds of thousands of years. It’s called a nervous system. When you eat too much sugar, you crash. When you don’t drink enough water, you get thirsty. When you run up a flight of stairs, your heart beats faster.
Yet, Silicon Valley has successfully convinced a generation that our natural human intuition and bodily awareness are completely useless unless they have been digitized, put on an interactive graph, and ran through an artificial intelligence model in Mountain View, California.
This isn’t about empowering your health; it’s about the financialization of your biology.
By convincing healthy, non-diabetic everyday people to wear a continuous needle in their arm to track minor, natural blood sugar spikes, Google and Abbott are turning your basic metabolic processes into a subscription service. They want you to buy a biowearable, pay for the replacement sensors every two weeks, and hand over your most intimate, molecular-level data so their AI can sell you targeted wellness products.
It is the ultimate corporate dream: putting a cash register directly in your bloodstream.
And let’s look at the timing of this launch. According to the Census Bureau’s latest Household Trends and Outlook Pulse Survey (HTOPS), a majority of American households (56.1%) used AI tools in mid-2025. But the data also shows a massive regional and class disconnect: wealthier, tech-heavy metropolitan areas like Boston are adopting these tools at record highs, while working-class New York and Philadelphia households are lagging behind.
Why? Because when you are struggling with a real-world economic squeeze, with personal savings hitting a historic low of 2.7% and utility prices climbing, you don’t have the luxury of spending hundreds of dollars a month on a “glorified Tamagotchi” for your bloodstream that alerts you when your bagel spikes your insulin.
We don’t need an AI health coach to tell us how to live. We need to turn off the screens, stop outsourcing our brains to Silicon Valley, and start trusting our own basic instincts again. You don’t need an algorithm to tell you that eating a fresh apple is better than a processed energy bar, and you certainly don’t need to pay Google for the privilege of hearing it.
